Medical devices, healthcare technology and the business of care
510(k) clearance · K262526

Safety lancet (XL)

Tianjin Huahong Technology Co., Ltd. · Decision date Sep 13, 2026

MEDTECHLEDGER EXPLANATIONK262526

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-13 for K262526, a traditional 510(k) submitted by Tianjin Huahong Technology Co., Ltd. of Tianjin, CN. The device is listed as Safety lancet (XL), under the classification name Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature, regulation number 878.4850, product code FMK, in the General & Plastic Surgery specialty and review panel. The application was received 07/22/2026.

SESE indicates clearance to market as substantially equivalent to a predicate device; it is not premarket approval. The record shows the review was not conducted by a third party, the product is not a combination product, and no predetermined change control plan was authorized. The source does not identify the predicate device, the specific components or design changes assessed, or any clinical performance data, so those details remain unknown from this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 13, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262526
Regulatory pathway
510(k) premarket notification
Product code
FMK
Decision code
SESE
Decision date
Sep 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature.

Product code
FMK
FDA device class
2

FDA decision timeline

  1. K262526 received

    Application receipt date recorded by FDA.

  2. K262526 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Tianjin Huahong Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tianjin

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records